177P - Effects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial

Suzette Delaloge ,Stephen Chia ,Beverly Moy ,Michael Gnant ,Frankie A Holmes ,Janine Mansi ,Marc Buyse ,Bent Ejlertsen ,Lesley Fallowfield ,David Cella ,Carlos H Barrios ,Gϋnter Von Minckwitz ,Hiroji Iwata ,Y Ye ,Audronė Cicėnienė ,Arlene Chan ,Susan Moran ,Snezhana Smichkoska ,Alan Auerbach ,M Martín Jiménez

doi:10.1093/annonc/mdx362.027

177P - Effects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial

Suzette Delaloge , Stephen Chia + Show 18 more

Open Access

https://doi.org/10.1093/annonc/mdx362.027

Copy DOI

Journal: Annals of Oncology	Publication Date: Sep 1, 2017
Citations: 2	License type: elsevier-specific: oa user license

#Effects Of Neratinib #Early-stage HER2 + Show 6 more

Abstract
Full-Text PDF
Similar Papers

Abstract

177P - Effects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.